Evaluation of bcr-abl fusion in lymphoblastic lymphoma by paraffin-section fluorescence in situ hybridization

被引：0
|
作者：
Tee, CM
Niehans, GA
Nguyen, PL
机构：
[1] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[2] Vet Adm Med Ctr, Minneapolis, MN 55417 USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 1999年 / 112卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
96
引用
收藏
页码：564 / 565
页数：2
相关论文
共 50 条
  • [11] CLINICAL DETECTION OF BCR-ABL FUSION BY INSITU HYBRIDIZATION IN CHRONIC MYELOGENOUS LEUKEMIA
    AMIEL, A
    YARKONI, S
    FEJGIN, M
    GABER, E
    NAGLER, A
    MANOR, Y
    LISHNER, M
    CANCER GENETICS AND CYTOGENETICS, 1993, 65 (01) : 32 - 34
  • [12] Fluorescence in situ hybridization patterns of BCR/ABL1 fusion in chronic myelogenous leukemia at diagnosis
    Poonam, Jain P.
    Mayur, Parihar
    Rayaz, Ahmed
    Aby, Abraham
    Auro, Vishwabandya
    Biju, George
    Vikram, Mathews
    Alok, Srivastava
    Vivi, Srivastava M.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2012, 55 (03) : 347 - 351
  • [13] Detection of the bcr/abl gene fusion in megakaryocytes of CML patients: A fluorescence in situ hybridization (FISH) study in paraffin sections of decalcified bone marrow biopsies
    Warner, M
    Nolte, M
    Ewig, M
    vonWasielewski, R
    Georgii, A
    LABORATORY INVESTIGATION, 1996, 74 (01) : 734 - 734
  • [14] Heterogeneous BCR-ABL Signal Patterns Identified By Fluorescence in Situ Hybridization Can Predict Leukemic Clonal Evolution and Poor Prognosis in BCR-ABL-Positive Leukemia
    Zhang Zhanglin
    Wan Lagen
    Jiang Mei
    Liu Shuyuan
    Guo Yang
    Li Fei
    BLOOD, 2017, 130
  • [15] T lymphoblastic lymphoma with BCR-ABL negative chronic myeloid leukaemia: a novel association
    Faizan, Mahwish
    Anwar, Saadia
    Ul Ain, Rahat
    Zafar, Huma
    Saqlain, Nazish
    Rathore, Zunaira
    ECANCERMEDICALSCIENCE, 2021, 15
  • [16] Improved sensitivity of BCR-ABL detection: A triple-probe three-color fluorescence in situ hybridization system
    Sinclair, PB
    Green, AR
    Grace, C
    Nacheva, EP
    BLOOD, 1997, 90 (04) : 1395 - 1402
  • [17] Does pretreatment fluorescence in situ hybridization for BCR-ABL predict imatinib-associated hematologic toxicity in chronic myeloid leukemia?
    Lima, Lisa M.
    Sampat, Keeran
    Assouline, Sarit
    Saxe, Debra
    Nault, Sharron
    Tighiouart, Mourad
    McLemore, Morgan
    Arellano, Martha
    Winton, Elliott
    Bernal-Mizrachi, Leon
    Cortes, Jorge
    Khoury, Hanna Jean
    LEUKEMIA & LYMPHOMA, 2011, 52 (06) : 1010 - 1016
  • [18] Near-haploid blast phase in a chronic myeloid leukemia detected by fluorescence in situ hybridization using a BCR-ABL probe
    Gancberg, D
    Dargent, JL
    Verhest, A
    Kentos, A
    Feremans, W
    Lohrisch, C
    Kornreich, A
    CANCER GENETICS AND CYTOGENETICS, 2001, 128 (02) : 172 - 174
  • [19] Clinical Significance of BCR-ABL Fusion Gene Subtypes in Chronic Myelogenous and Acute Lymphoblastic Leukemias
    Ye, Yuan-Xin
    Zhou, Juan
    Zhou, Yan-Hong
    Zhou, Yi
    Song, Xing-Bo
    Wang, Jun
    Lin, Li
    Ying, Bin-Wu
    Lu, Xiao-Jun
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (22) : 9961 - 9966
  • [20] Standardization criteria for the detection of BCR/ABL fusion in interphase nuclei of chronic myelogenous leukemia patients by fluorescence in situ hybridization
    Cohen, N
    Novikov, I
    Hardan, I
    Esa, A
    Brok-Simoni, F
    Amariglio, N
    Rechavi, G
    Ben-Bassat, I
    Trakhtenbrot, L
    CANCER GENETICS AND CYTOGENETICS, 2000, 123 (02) : 102 - 108
12345